3,692
Views
25
CrossRef citations to date
0
Altmetric
Review

The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib

, , , , &
Pages 971-991 | Received 30 Jul 2019, Accepted 28 Oct 2019, Published online: 13 Nov 2019

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.